Add to Calendar
5/5/2022 8:30:00 AM
5/5/2022 8:30:00 PM
2022 State of Possible Conference
MassBio's annual State of Possible Conference celebrates how the life sciences make the impossible possible. We will tap today’s brightest minds for engaging conversations on the latest developments in our industry, key insights from the past year, and building a better future for patients around the world. This year's conference will explore the theme "The Massachusetts BioPharma Ecosystem in the Post- Covid Era."
Join MassBio and more than 500 attendees for a day of networking, keynotes, and panel discussions from some of the most inspiring voices in the industry, culminating in a reception celebrating the life sciences community. This is our most popular event so you will want to reserve your spot early. Royal Sonesta Boston, 40 Edwin Land Blvd Cambridge MA 02142
Join MassBio and more than 500 attendees for a day of networking, keynotes, and panel discussions from some of the most inspiring voices in the industry, culminating in a reception celebrating the life sciences community. This is our most popular event so you will want to reserve your spot early. Royal Sonesta Boston, 40 Edwin Land Blvd Cambridge MA 02142
Founder and CEO, PureTech
Daphne Zohar is the Founder and Chief Executive Officer of PureTech, and she has served as a member of PureTech's Board of Directors since the Company's founding. She has also served as the founding Chief Executive Officer for a number of PureTech's Founded Entities. A successful entrepreneur, Ms. Zohar created PureTech, assembling a leading team to help implement her vision for the Company, and was a key participant in fundraising, business development and establishing the underlying programs and platforms that have resulted in PureTech's substantial pipeline, which is comprised of 25 therapeutics and therapeutic candidates being advanced via the Company’s Wholly Owned Pipeline and Founded Entities, including two that have been cleared for marketing by the U.S. Food and Drug Administration and granted marketing authorization in the European Economic Area. Ms. Zohar has been recognized as a top leader and innovator in biotechnology by a number of sources, including EY, BioWorld, MIT Technology Review, The Boston Globe and Scientific American.